Anavex Life Sciences Provides Comprehensive Regulatory Update Anavex Life Sciences (Nasdaq: AVXL) provided a regulatory update on March 30, 2026: the company withdrew its EU marketing authorization application for oral blarcamesine in early Alzheimer’s disease and will gather additional data while continuing dialogue with the EMA and CHMP.Anavex also submitted additional data to the U.S. FDA to discuss potential pathways toward an NDA for early Alzheimer’s disease and is engaging EU regulators for blarcamesine in Parkinson’s disease and rare disorders including Rett syndrome.

#AVXL Anavex Life Sciences Provides Comprehensive Regulatory Update

www.stocktitan.net/news/AVXL/anavex-life-sc...

Pomerantz Law Firm Initiates Investigation into Anavex Life Sciences Corp. Investors' Claims Amidst Regulatory Concerns Pomerantz LLP investigates Anavex Life Sciences Corp. following the withdrawal of its application for Alzheimer's treatment. Investors are urged to email for details.

Pomerantz Law Firm Initiates Investigation into Anavex Life Sciences Corp. Investors' Claims Amidst Regulatory Concerns #USA #New_York #Pomerantz_Law_Firm #Anavex_Life_Sciences #AVXL

Original post on benzinga.com

Crude Oil Moves Lower; Cintas Raises FY2026 Forecast The Dow Jones index gained over 300 points, with the S&P 500 and NASDAQ also rising. Cintas Corp posted strong earnings and raised its forec...

#ARM #AVXL #BRZE #CTAS #Equities #MAZE #Mid-Afternoon #Market […]

[Original post on benzinga.com]

Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease Anavex (Nasdaq: AVXL) withdrew its EU marketing authorization application for blarcamesine as an add-on therapy for early Alzheimer’s disease on March 25, 2026 after the EMA’s CHMP indicated it would not be in a position to issue a positive opinion.The company said it will consider CHMP feedback, gather additional data, conduct further analyses, and continue clinical development while maintaining engagement with regulators and patient organizations.

#AVXL Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease

www.stocktitan.net/news/AVXL/anavex-life-sc...

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations! PM Top Unusual

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations!

PM Top Unusual Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #JOBY 72% OTM
2. #QURE 64% OTM
3. #REPL 45% OTM
4. #AVXL 33% OTM
5. #TSLA 31% OTM

#OptionFlow #OptionsTrading #Trading

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expir

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expirations.

PM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#REPL, #AVXL, #WVE, #IPI, #ULTA

#OptionFlow #OptionsTrading #Trading

Alzheimer’s study points to cell-cleanup failure before plaques form UC researchers in PNAS Nexus say aging-related autophagy failure can raise intracellular amyloid beta, aligning with Anavex blarcamesine data.

#AVXL New Scientific Findings Highlight Hypothesis of Autophagy Failure as a Precursor of Amyloid Beta and Tau Pathology in Alzheimer’s Disease

www.stocktitan.net/news/AVXL/new-scientific...

Anavex Life Sciences Presents Significant Treatment Effects of Blarcamesine in New Advanced Alpha-Synuclein Model of Parkinson’s Disease at AD/PD 2026 Conference Anavex (Nasdaq: AVXL)/b) reported new preclinical data showing and produced a dopaminergic nerve fiber regrowth biomarker in striatum after six weeks in a new dual‑hit Parkinson’s disease model.The model combines alpha‑synuclein accumulation and noradrenergic degeneration; results were presented at AD/PD 2026 and the company continues advancing clinical development for early Parkinson’s disease.

#AVXL Anavex Life Sciences Presents Significant Treatment Effects of Blarcamesine in New Advanced Alpha-Synuclein Model of Parkinson’s Disease at AD/PD 2026 Conference

www.stocktitan.net/news/AVXL/anavex-life-sc...

🚨 Institutions #optionsvolume surge detected! Weekly Top Momentum Activity from 🔥 INSIDERFINANCE.

🚨 Institutions #optionsvolume surge detected!

Weekly Top Momentum Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #FSK 423.8x
2. #ECG 117.4x
3. #AVXL 85.8x
4. #OUT 30.0x
5. #JBS 22.4x

#OptionFlow #OptionsTrading #Trading

#AVXL #fc8b93d3-5a58-4f82-9552-8cd6c677d614 #earningscall-transcripts

Origin | Interest | Match

Edelson Lechtzin LLP Investigates Anavex Life Sciences Corp. Due to Potential Violations Edelson Lechtzin LLP has announced a probe into Anavex Life Sciences Corp. for potential security law violations, particularly concerning misleading information about company performance.

Edelson Lechtzin LLP Investigates Anavex Life Sciences Corp. Due to Potential Violations #USA #Edelson_Lechtzin #Newtown #Anavex_Life_Sciences #AVXL

Pomerantz Law Firm Launches Investigation into Anavex Life Sciences Investors' Claims Pomerantz LLP is currently investigating claims for investors of Anavex Life Sciences Corp. related to potential securities fraud and market irregularities.

Pomerantz Law Firm Launches Investigation into Anavex Life Sciences Investors' Claims #United_States #New_York #Pomerantz_LLP #Anavex_Life_Sciences #AVXL

Investors Urged to Act: Pomerantz Law Firm Investigates Anavex Life Sciences Corp Claims Pomerantz Law Firm is probing potential securities fraud claims against Anavex Life Sciences Corp, following a significant stock drop. Investors are encouraged to reach out.

Investors Urged to Act: Pomerantz Law Firm Investigates Anavex Life Sciences Corp Claims #United_States #New_York #Pomerantz_LLP #Anavex_Life_Sciences #AVXL

Anavex Life Sciences Submitted Request for EMA to Re-Examine Its Opinion Anavex Life Sciences (Nasdaq: AVXL) requested that the European Medicines Agency (EMA) re-examine its opinion on blarcamesine for early Alzheimer’s disease on December 18, 2025.The company said the re-examination will be led by a different rapporteur and co-rapporteur and that Anavex asked the EMA to consult a Scientific Advisory Group to provide an independent recommendation. Anavex is a clinical-stage biopharmaceutical company developing treatments for Alzheimer’s and other CNS disorders.The release reiterates that blarcamesine is investigational, that efficacy and safety conclusions are not claimed, and that approval is not guaranteed.

#AVXL Anavex Life Sciences Submitted Request for EMA to Re-Examine Its Opinion

www.stocktitan.net/news/AVXL/anavex-life-sc...

Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease Anavex Life Sciences (Nasdaq: AVXL) announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a negative opinion on the marketing authorisation application for blarcamesine to treat early Alzheimer’s disease following an oral examination in November.The company intends to request a CHMP re-examination; EMA rules allow a re-examination by a different set of reviewers who will conduct a new, independent assessment. The release reiterates that investigational uses are not conclusions about efficacy or safety and that approval is not guaranteed.

#AVXL Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease

www.stocktitan.net/news/AVXL/anavex-life-sc...

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expir

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expirations.

AM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#FRMI, #VRT, #RH, #MSTR, #AVXL

#OptionFlow #OptionsTrading #Trading

Pomerantz Law Firm Launches Inquiry for Anavex Life Sciences Corp. Investors Pomerantz LLP is investigating potential securities fraud claims against Anavex Life Sciences Corp. after recent troubling news. Investors are urged to respond.

Pomerantz Law Firm Launches Inquiry for Anavex Life Sciences Corp. Investors #USA #New_York #Pomerantz_Law_Firm #Anavex_Life_Sciences #AVXL

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expir

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expirations.

PM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#BE, #AVXL, #OPEN, #FUTU, #BITF

#OptionFlow #OptionsTrading #Trading

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations! PM Top Unusual

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations!

PM Top Unusual Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #OMER 47% OTM
2. #RKLB 35% OTM
3. #PLTR 32% OTM
4. #BE 30% OTM
5. #AVXL 28% OTM

#OptionFlow #OptionsTrading #Trading

Top Stocks with Earnings This Week: Costco, Ulta and More - Salesforce (NYSE:CRM) Retail investors are prepping for a lighter week of corporate earnings featuring Costco, MongoDB, Ulta and more.

Top Stocks with Earnings This Week: Costco, MongoDB, Ulta and More Retail investors are prepping for a lighter week of corporate earnings featuring Costco, MongoDB, Ulta and more. read more

#AEO #AI #ATON #AVXL #CHPT #COST #CRDO #CRM #CRWD #CTRM #DG

Origin | Interest | Match

Anavex Life Sciences Reports Fiscal 2025 Fourth Quarter Financial Results and Provides Business Update Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's

#AVXL Anavex Life Sciences Reports Fiscal 2025 Fourth Quarter Financial Results and Provides Business Update

www.stocktitan.net/news/AVXL/anavex-life-sc...

Anavex Life Sciences to Announce Fiscal 2025 Fourth Quarter Financial Results on Tuesday, November 25, 2025 Anavex Life Sciences (Nasdaq: AVXL) will report fiscal 2025 fourth quarter and year‑end financial results on Tuesday, November 25, 2025. Management will host a conference call and live webcast on November 25 at 8:30 am ET to review results and recent corporate developments, followed by a Q&A session.Investors can access the live webcast at www.anavex.com or join by phone at 1 929 205 6099 (Meeting ID# 839 7768 4735, passcode 825109). A replay will be available on the company website for up to 30 days.

#AVXL Anavex Life Sciences to Announce Fiscal 2025 Fourth Quarter Financial Results on Tuesday, November 25, 2025

www.stocktitan.net/news/AVXL/anavex-life-sc...

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations! Weekly Top Unu

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations!

Weekly Top Unusual Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #GLXY 74% OTM
2. #HIMS 65% OTM
3. #HUT 54% OTM
4. #VFF 43% OTM
5. #AVXL 42% OTM

#OptionFlow #OptionsTrading #Trading

📢 Stocks Trending NOW: #TSLA #MSTR #CDTX #COIN #NVDA #IVVD #AVXL #WMT #ASBP #HOOD

Anavex Life Sciences Provides Regulatory Update on Blarcamesine for Early Alzheimer's Disease Anavex (Nasdaq: AVXL) said the CHMP delivered a negative trend vote on its MAA for oral blarcamesine for early Alzheimer’s disease after an oral explanation; a formal CHMP opinion is expected at the December meeting.The company intends to request re-examination of the CHMP opinion when adopted and will provide additional biomarker data. Separately, FDA CDER advised Anavex to request a meeting to discuss its Alzheimer’s clinical trial results.

#AVXL Anavex Life Sciences Provides Regulatory Update on Blarcamesine for Early Alzheimer's Disease

www.stocktitan.net/news/AVXL/anavex-life-sc...

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations! PM Top Unusual

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations!

PM Top Unusual Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #QBTS 70% OTM
2. #HIMS 65% OTM
3. #AVXL 44% OTM
4. #HUT 40% OTM
5. #RGTI 38% OTM

#OptionFlow #OptionsTrading #Trading

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expir

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expirations.

PM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#AVXL, #HUT, #SMCI, #CIFR, #SMR

#OptionFlow #OptionsTrading #Trading

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations! PM Top Unusual

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations!

PM Top Unusual Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #CRCL 56% OTM
2. #SMCI 33% OTM
3. #AVXL 26% OTM
4. #APLD 25% OTM
5. #FLNC 25% OTM

#OptionFlow #OptionsTrading #Trading

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expir

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expirations.

PM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#AVXL, #APLD, #FLNC, #OPEN, #HPK

#OptionFlow #OptionsTrading #Trading